A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder

Introduction: Metabolic risk factors, termed metabolic syndrome, which include obesity, diabetes, dyslipidemia, and hypertension, are more common in patients with bipolar disorder than in the general population. Moreover, medications used to treat bipolar disorder carry some risk of worsening metabo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: McIntyre, Roger S., McElroy, Susan L., Eudicone, James M., Forbes, Robert A., Carlson, Berit X., Baker, Ross A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Physicians Postgraduate Press, Inc. 2011
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3304683/
https://ncbi.nlm.nih.gov/pubmed/22454801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.11m01182
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky